A global research priority agenda to advance public health responses to fatty liver diseaseSaleh A. Alqahtani, Marco Arrese, Ramón Bataller et al.|Journal of Hepatology|2023Cited by 132
A global action agenda for turning the tide on fatty liver diseaseJeffrey V. Lazarus, Henry E. Mark, Alina M. Allen et al.|Hepatology|2023Cited by 90
Opportunities and challenges following approval of resmetirom for MASH liver diseaseJeffrey V. Lazarus, Paul Brennan, Dana Ivancovsky‐Wajcman et al.|Nature Medicine|2024Cited by 57